Literature DB >> 21431402

Primary neuroendocrine tumors of the main pancreatic duct: a rare entity.

Thomas Walter1, Valérie Hervieu, Mustapha Adham, Rodica Gincul, Gilles Poncet, Frank Pilleul, Jean-Alain Chayvialle, Christian Partensky, Catherine Lombard-Bohas, Jean-Yves Scoazec.   

Abstract

Very few cases of primary neuroendocrine tumors of the main pancreatic duct have been reported. This paucity has hampered an accurate description of the distinctive clinical and pathological features of these tumors and the correct evaluation of the diagnostic and therapeutic problems which they may raise. We report here five additional cases in order to underline the clinical, histological, and immunohistochemical features of this tumor entity. There were three male and two female, aged 43-72 years; in all patients, but one, who presented with epigastric pain, the diagnosis was made after the incidental discovery of a dilatation of the main pancreatic duct. The preoperative diagnosis was ductal adenocarcinoma in one case, IPMN in one case and neoplastic stenosis of unknown etiology in four cases. Surgical resection was performed in all cases. The diagnosis of neuroendocrine tumor was made at histological examination. All lesions were small, ranging from 5 to 15 mm. They had a predominantly intramural growth. The growth pattern was nodular in three cases, circumferential in two; there was no intra-luminal component. All cases were well-differentiated neuroendocrine neoplasms of low histological grade (G1); four cases expressed serotonin. One case was associated with regional lymph node metastases. All cases were cured by surgery alone; no recurrence was observed at the end of the follow-up period. In conclusion, despite their rarity, primary neuroendocrine tumors of the main pancreatic duct deserve recognition and must be considered in the etiological diagnosis of ductal stenosis.

Entities:  

Mesh:

Year:  2011        PMID: 21431402     DOI: 10.1007/s00428-011-1067-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  35 in total

1.  Nonfunctioning islet cell tumor with a unique pattern of tumor growth.

Authors:  K Shimizu; K Shiratori; F Toki; M Suzuki; T Imaizumi; K Takasaki; M Kobayashi; N Hayashi
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

2.  Pancreatic glucagonoma as a rare cause of chronic obstructive pancreatitis.

Authors:  O Pech; T Lingenfelser; P Wünsch
Journal:  Gastrointest Endosc       Date:  2000-10       Impact factor: 9.427

3.  Pancreatic endocrine tumor in multiple endocrine neoplasia type 1 syndrome with intraductal growth into the main pancreatic duct.

Authors:  Matteo Fassan; Sara Pizzi; Claudio Pasquali; Anna R Parenti
Journal:  Pancreas       Date:  2009-04       Impact factor: 3.327

4.  Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth.

Authors:  Tadashi Terada; Masaharu Kawaguchi; Kazuo Furukawa; Yasutomo Sekido; Yoshiyuki Osamura
Journal:  Pathol Int       Date:  2002-11       Impact factor: 2.534

Review 5.  Bile duct carcinoid tumors: an uncommon disease but with a good prognosis?

Authors:  Catherine Hubert; Christine Sempoux; Anne Berquin; Pierre Deprez; François Jamar; Jean-François Gigot
Journal:  Hepatogastroenterology       Date:  2005 Jul-Aug

6.  Preoperative cytodiagnosis of primitive carcinoid tumor of the Wirsung duct: a case report with immunocytochemical study.

Authors:  A P Dei Tos; L Laurino; M De Boni; C Doglioni
Journal:  Diagn Cytopathol       Date:  1993-08       Impact factor: 1.582

7.  Acute pancreatitis associated with neuroendocrine tumor of the pancreas.

Authors:  José Jukemura; André Luis Montagnini; Marcos Vinícius Perini; José Luiz Jesus de Almeida; Joaquim José Gama Rodrigues; José Eduardo Monteiro da Cunha
Journal:  JOP       Date:  2006-01-11

Review 8.  Carcinoid tumor of the pancreas with obstructive pancreatitis.

Authors:  E Nagai; K Yamaguchi; H Hashimoto; T Sakurai
Journal:  Am J Gastroenterol       Date:  1992-03       Impact factor: 10.864

9.  Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.

Authors:  Jorge Albores-Saavedra; Kristen Batich; Sarah Hossain; Donald E Henson; Arnold M Schwartz
Journal:  Ann Diagn Pathol       Date:  2009-12       Impact factor: 2.090

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  4 in total

1.  Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement.

Authors:  Chad M McCall; Chanjuan Shi; Alison P Klein; Björn Konukiewitz; Barish H Edil; Trevor A Ellison; Christopher L Wolfgang; Richard D Schulick; Günter Klöppel; Ralph H Hruban
Journal:  Hum Pathol       Date:  2012-01-04       Impact factor: 3.466

2.  Intraductal polypoid lipid-rich neuroendocrine tumor of the pancreas with entrapped ductules: case report and review of the literature.

Authors:  Jaclyn Frances Hechtman; Bernardo Franssen; Daniel M Labow; Ronald E Gordon; Christopher J DiMaio; Eric J Wilck; Gonzalo Carrasco-Avino; Hongfa Zhu
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

Review 3.  Intraductal papillary mucinous neoplasm of the pancreas: an update.

Authors:  Shu-Yuan Xiao
Journal:  Scientifica (Cairo)       Date:  2012-11-28

Review 4.  Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.

Authors:  Nikolaos Tsoukalas; Eleftherios Chatzellis; Dimitra Rontogianni; Krystallenia I Alexandraki; Georgios Boutzios; Anna Angelousi; Gregory Kaltsas
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.